GLP-1 medications are changing how people think about weight loss and how they actually lose weight, driving changes in views about obesity care among health systems and providers and affecting the broader US economy
Patients who struggle with metabolic resistance often experience hormonal dysregulation that makes weight loss extremely difficult despite lifestyle efforts
Kidney problems, including kidney failure
Moreover, GLP-1 delays gastric emptying and inhibits glucagon secretion from pancreatic -cells, further contributing to glycemic stabilization
In clinical research, supplementation enhanced high-intensity exercise capacity, improved repeated sprint performance, and delayed fatigue
GLP-1 (Glucagon-Like Peptide-1) is a naturally occurring hormone in your body